Editorial. Discusses the treatment of erectile dysfunction, or impotence. What proper treatment requires; Causes; The development, since the mid-1980s, of the vacuum erection device and the introduction of intracavernous-injection therapy; Details about natural erections; Details of a study on the ...
Long-term follow-up of patients receiving injection therapy for erectile dysfunction Objectives. During the last decade, vasoactive intracavernosal pharmacotherapy (VIP) has been used extensively for the treatment of erectile dysfunction. H... Chandru,P.,Sundaram,... - 《Urology》...
Penile fibrosis in intracavernosal prostaglandin E1 injection therapy for erectile dysfunction. Int J Impot Res 1997;9:225-9.Chew KK, Earle CM, Stuckey BGA, Keogh EJ: Penile fibrosis in intracavernosal PGE1 therapy for erectile dysfunction . Int J Impot Res 1997, 9 :225–229....
Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.For injection dosage form: For the treatment of impotence: Adults— 0.5 to 1 milligram (mg) ...
A patient developed bilateral cystoid macular edema following intracorporeal injection of alprostadil, a prostaglandin E1 for treatment of erectile dysfunction. The edema resolved following treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, with subsequent recovery in visual ...
Currently there are three main agents for intracavernosal injection (ICI) therapy and one agent for intraurethral therapy approved by the FDA for the treatment of erectile dysfunction (ED). These effective agents were the focus of intense interest in the mid1990s, but were quickly relegated to ...
Prostaglandin E1 for treatment of erectile dysfunction. Cochrane Database Syst Rev 2004; 2: Art. No. CD001784. El-Sakka AI . Intracavernosal prostaglandin E1 self versus office injection therapy in patients with erectile dysfunction. Int J Impot Res 2006; 18: 180–185. CAS PubMed Google ...
Isolation of Adipose derived regenerative cells for the treatment of erectile dysfunction following radical prostatectomy. J Vis Exp. 2021. https://doi.org/10.3791/59183. Article PubMed Google Scholar Dhumale P, et al. CD31 defines a subpopulation of human adipose-derived regenerative cells with...
generally should not be used in men for whom sexual activity is inadvisable because of their underlying cardiovascular status. In addition, the evaluation of erectile dysfunction should include a determination of potential underlying causes and the identification of appropriate treatment following a complete...
Virag R . Intracavernous injection of papaverine for erectile failure.Lancet1982;2: 938. CASPubMedGoogle Scholar Shmueli J, Israilov S, Segenreich E, Baniel J, Livne P . Progressive treatment of erectile dysfunction with intracorporeal injections of different combinations of vasoactive agents.Int ...